GlaxoSmithKline (GSK)

NYSE:GSK

US Market

GSK

GlaxoSmithKline

RESEARCH TOOLSreports

GlaxoSmithKline (GSK) Ownership - Who Owns GlaxoSmithKline?

5,214 Followers

GlaxoSmithKline (GSK) Ownership Overview

6.71% Mutual Funds

10.10% Other Institutional Investors

0.39% ETFs

82.80% Public Companies and Individual Investors

The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 17.20% of the company’s stock is owned by Institutional Investors, and 82.80% is owned by Public Companies and Individual Investors.

The ownership structure of GlaxoSmithKline (GSK) stock is a mix of institutional, retail, and individual investors. Approximately 10.49% of the company’s stock is owned by Institutional Investors, 6.71% is owned by Insiders, and 82.80% is owned by Public Companies and Individual Investors.

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2025	Pzena Investment Management Llc	xxxxxxxxxxxxx	$659293
Dec 31, 2025	Gallacher Capital Management Llc	xxxxxxxxxxxxx	$773311
Dec 31, 2025	Auxier Asset Management	xxxxxxxxxxxxx	$1350169
Dec 31, 2025	Causeway Capital Management Llc	xxxxxxxxxxxxx	$1662308

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
John A. Gunn	68,517,969	Institution	3.37%	3,715,729,459
	55,475,472	Institution	2.73%	3,008,434,847
Ken Fisher	33,195,985	Institution	1.63%	1,800,218,267
Theofanis Kolokotrones	25,130,160	Institution	1.24%	1,362,808,577
	18,142,650	Institution	0.89%	983,875,910
	10,918,873	Institution	0.54%	592,130,483
	8,264,464	Institution	0.41%	448,181,883
	5,702,194	Institution	0.28%	309,229,981
	4,447,100	Institution	0.22%	241,166,233
George Davis Jr	3,657,931	Institution	0.18%	198,369,598

Top Mutual Fund Holders

Holder	# of Shares	Type	% Holding	Value
	55,475,472	Institution	2.73%	3,008,434,847
	18,142,650	Institution	0.89%	983,875,910
	10,918,873	Institution	0.54%	592,130,483
	8,264,464	Institution	0.41%	448,181,883
	5,702,194	Institution	0.28%	309,229,981
	4,447,100	Institution	0.22%	241,166,233
	3,544,080	Institution	0.17%	192,195,458
	3,487,775	Institution	0.17%	189,142,038
	3,053,917	Institution	0.15%	165,613,919
	2,766,300	Institution	0.14%	150,016,449

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Avantis International Equity ETF	1,178,586	Institution	0.06%	63,572,929
VanEck Pharmaceutical ETF	1,079,497	Institution	0.05%	58,228,068
Fidelity Enhanced International ETF	916,190	Institution	0.05%	49,419,289
Fidelity Tactical High Income Fund Trust Units	680,400	Institution	0.03%	45,797,623
First Trust Value Line Dividend Index Fund	653,279	Institution	0.03%	35,172,541
Avantis International Large Cap Value ETF	253,909	Institution	0.01%	13,695,851
GMO International Value ETF	250,123	Institution	0.01%	13,491,635
Hartford Multifactor Developed Markets (ex-US) ETF	245,479	Institution	0.01%	13,241,137
AQE Core ETF	216,812	Institution	0.01%	11,694,839
Xtrackers S&P 500 Swap UCITS ETF	193,705	Institution	<0.01%	10,448,448

FAQ

Who Owns GlaxoSmithKline (GSK)?

Currently, no data Available

What percentage of GlaxoSmithKline (GSK) stock is held by institutional investors?

According to the latest TipRanks data, approximately 10.10% of GlaxoSmithKline (GSK) stock is held by institutional investors.

What percentage of GlaxoSmithKline (GSK) stock is held by retail investors?

According to the latest TipRanks data, approximately 82.80% of GlaxoSmithKline (GSK) stock is held by retail investors.

Who owns the most shares of GlaxoSmithKline (GSK)?

John A. Gunn owns the most shares of GlaxoSmithKline (GSK).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.